HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.

Abstract
The authors wanted to verify if in clinical practice (Intensive Care Unit patients), the association of azlocillin with an aminoglycoside offers substantial advantages compared to use of azlocillin alone. Their results show that azlocillin alone is potent enough to be used in the treatment of severe infections.
AuthorsM Mergoni, N Stocchetti, A De Cristofaro, M Antonioni, P Zuccoli
JournalChemioterapia : international journal of the Mediterranean Society of Chemotherapy (Chemioterapia) Vol. 6 Issue 4 Pg. 286-9 (Aug 1987) ISSN: 0392-906X [Print] Italy
PMID3652280 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Amikacin
  • Azlocillin
Topics
  • Adult
  • Aged
  • Amikacin (therapeutic use)
  • Azlocillin (therapeutic use)
  • Bacterial Infections (drug therapy)
  • Critical Care (methods)
  • Cross Infection (drug therapy)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: